martes, 12 de junio de 2018

Final Recommendation Statement: Cardiovascular Disease Risk: Screening With Electrocardiography - US Preventive Services Task Force

Final Recommendation Statement: Cardiovascular Disease Risk: Screening With Electrocardiography - US Preventive Services Task Force



Final Recommendation Statement:

Screening for Cardiovascular Disease Risk With Electrocardiography

Final Recommendation Statement: Screening for Cardiovascular Disease Risk With Electrocardiography

The U.S. Preventive Services Task Force released today a final recommendation statement on screening for cardiovascular disease (CVD) risk with electrocardiography (ECG). The Task Force recommends against ECG screening in adults at low risk for CVD and finds insufficient evidence on ECG screening in those at medium or high risk. To view the recommendation and the evidence on which it is based, please go here. The final recommendation statement can also be found in the June 12 online issue of JAMA.
The Final Recommendation Statement Is Available
read the final recommendation

FINAL RECOMMENDATION SUMMARY

Population
Recommendation
Grade
Adults at low risk of CVD events
The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease CVD events in asymptomatic adults at low risk of CVD events.
D
Adults at intermediate or high risk of CVD events
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events.
I

WHY THIS MATTERS

Seth Landefeld
"Adding ECG screening for people at low risk of a heart attack or stroke is unlikely to help prevent CVD events and can actually cause harms,” says Task Force member Seth Landefeld, M.D. “Anyone who has questions about their risk for heart disease, heart attack, or stroke should talk to their clinician.”

WHERE WE ARE IN THE PROCESS

Draft
Research Plan
Final
Research Plan
Draft
Recommendation / Draft Evidence Review 
Final Recommendation / Evidence Summary

No hay comentarios: